143 related articles for article (PubMed ID: 18998064)
1. Disparities in receipt of lymph node biopsy among early-stage female breast cancer patients.
Halpern MT; Chen AY; Marlow NS; Ward E
Ann Surg Oncol; 2009 Mar; 16(3):562-70. PubMed ID: 18998064
[TBL] [Abstract][Full Text] [Related]
2. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
3. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer.
Black DM; Jiang J; Kuerer HM; Buchholz TA; Smith BD
JAMA Surg; 2014 Aug; 149(8):788-96. PubMed ID: 25073831
[TBL] [Abstract][Full Text] [Related]
4. Disparities in the Use of Sentinel Lymph Node Dissection for Early Stage Breast Cancer.
Nayyar A; Strassle PD; Schlottmann F; Jadi J; Moses CG; Black JA; Gallagher KK; McGuire KP
J Surg Res; 2020 Oct; 254():31-40. PubMed ID: 32408028
[TBL] [Abstract][Full Text] [Related]
5. Disparities of Management of the Axilla in Women With Clinically Node Negative Breast Cancer.
Aubry S; Strassle PD; Maduekwe U; Downs-Canner S
J Surg Res; 2020 Dec; 256():13-22. PubMed ID: 32679224
[TBL] [Abstract][Full Text] [Related]
6. Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy.
Rescigno J; Zampell JC; Axelrod D
Ann Surg Oncol; 2009 Mar; 16(3):687-96. PubMed ID: 19101768
[TBL] [Abstract][Full Text] [Related]
7. Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer.
Reeder-Hayes KE; Bainbridge J; Meyer AM; Amos KD; Weiner BJ; Godley PA; Carpenter WR
Breast Cancer Res Treat; 2011 Aug; 128(3):863-71. PubMed ID: 21340480
[TBL] [Abstract][Full Text] [Related]
8. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
Mann JM; Wu X; Christos P; Nagar H
Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423
[TBL] [Abstract][Full Text] [Related]
9. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
10. Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery?
Yip CH; Taib NA; Tan GH; Ng KL; Yoong BK; Choo WY
World J Surg; 2009 Jan; 33(1):54-7. PubMed ID: 18958521
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
13. Perioperative outcomes and disparities in utilization of sentinel lymph node biopsy in minimally invasive staging of endometrial cancer.
Albright BB; Nasioudis D; Byrne ME; Latif NA; Ko EM; Haggerty AF
Gynecol Oncol; 2020 Dec; 159(3):758-766. PubMed ID: 32981697
[TBL] [Abstract][Full Text] [Related]
14. Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt.
Dominici LS; Sineshaw HM; Jemal A; Lin CC; King TA; Freedman RA
Breast Cancer Res Treat; 2018 Jan; 167(2):555-566. PubMed ID: 28990127
[TBL] [Abstract][Full Text] [Related]
15. Axillary lymph node status of T1 primary breast cancer in a diverse population.
Madan AK; Macareo L; Winfrey K; Beech DJ
Am Surg; 2001 Jan; 67(1):71-4. PubMed ID: 11206902
[TBL] [Abstract][Full Text] [Related]
16. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis.
Travagli JP; Atallah D; Mathieu MC; Rochard F; Camatte S; Lumbroso J; Garbay JR; Rouzier R
Eur J Surg Oncol; 2003 May; 29(4):403-6. PubMed ID: 12711299
[TBL] [Abstract][Full Text] [Related]
18. No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial.
Jung JG; Ahn SH; Lee S; Kim EK; Ryu JM; Park S; Lim W; Jung YS; Chung IY; Jeong J; Chang JH; Shin KH; Chang JM; Moon WK; Han W
BMC Cancer; 2022 Feb; 22(1):189. PubMed ID: 35184724
[TBL] [Abstract][Full Text] [Related]
19. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
20. Utilization of lymph node dissection, race/ethnicity, and breast cancer outcomes.
Nurgalieva ZZ; Franzini L; Morgan RO; Vernon SW; Du XL
Am J Manag Care; 2013 Oct; 19(10):805-10. PubMed ID: 24304159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
